Efficacy and tolerability of fixed-dose combination of simvastatin plus ezetimibe in patients with primary hypercholesterolemia: Results of a multicentric trial from India

Pinakini K. Shankar; Rama Bhat; Mukhyaprana Prabhu; Bandi Partha Saradhi Reddy; M. Srinivasa Reddy; Mohan Reddy

doi:10.1016/j.jacl.2007.07.009

Efficacy and tolerability of fixed-dose combination of simvastatin plus ezetimibe in patients with primary hypercholesterolemia: Results of a multicentric trial from India

Journal of Clinical Lipidology ◽

10.1016/j.jacl.2007.07.009 ◽

2007 ◽

Vol 1 (4) ◽

pp. 264-270

Author(s):

Pinakini K. Shankar ◽

Rama Bhat ◽

Mukhyaprana Prabhu ◽

Bandi Partha Saradhi Reddy ◽

M. Srinivasa Reddy ◽

...

Keyword(s):

Fixed Dose Combination ◽

Fixed Dose ◽

Primary Hypercholesterolemia ◽

Dose Combination

Download Full-text

Efficacy and Tolerability of a Fixed-Dose Combination of Rosuvastatin and Ezetimibe Compared with a Fixed-Dose Combination of Simvastatin and Ezetimibe in Brazilian Patients with Primary Hypercholesterolemia or Mixed Dyslipidemia: A Multicenter, Randomized Trial

Current Therapeutic Research ◽

10.1016/j.curtheres.2020.100595 ◽

2020 ◽

Vol 93 ◽

pp. 100595

Author(s):

Antonio Carlos Amedeo Vattimo ◽

Francisco Antonio Helfestein Fonseca ◽

Douglas Costa Morais ◽

Larissa Fontes Generoso ◽

Renata Herrera ◽

...

Keyword(s):

Randomized Trial ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Primary Hypercholesterolemia ◽

Multicenter Randomized Trial ◽

Mixed Dyslipidemia ◽

Dose Combination

Download Full-text

Efficacy and safety of aclidinium/formoterol fixed-dose combination in patients with COPD, stratified by ICS use

Pneumologie ◽

10.1055/s-0036-1572276 ◽

2016 ◽

Vol 70 (S 01) ◽

Cited By ~ 1

Author(s):

ED Bateman ◽

K Chapman ◽

S Rennard ◽

L Rekeda ◽

M Moya ◽

...

Keyword(s):

Fixed Dose Combination ◽

Fixed Dose ◽

Efficacy And Safety ◽

Dose Combination

Download Full-text

Overall safety and cardiovascular safety of fixed-dose combination of aclidinium/formoterol compared to salmeterol/fluticasone in patients with COPD

Pneumologie ◽

10.1055/s-0036-1572086 ◽

2016 ◽

Vol 70 (S 01) ◽

Author(s):

J Beier ◽

C Vogelmeier ◽

R Mroz ◽

S Pascual ◽

RM Segarra ◽

...

Keyword(s):

Fixed Dose Combination ◽

Fixed Dose ◽

Cardiovascular Safety ◽

Dose Combination

Download Full-text

The hypolipidemic and hepatoprotective efficacies of a fixed-dose combination of essential phospholipids with methionine (EPL+M) during atorvastatin (A) therapy in hyperlipidemic patients with cardiovascular diseases (CVD) and type 2 diabetes mellitus (DM) (OLYMP trial)

Endocrine Abstracts ◽

10.1530/endoabs.49.ep598 ◽

2017 ◽

Author(s):

M G Bubnova ◽

D M Aronov ◽

Marina Bubnoa ◽

David Aronov

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Cardiovascular Diseases ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Dose Combination ◽

Essential Phospholipids

Download Full-text

135-OR: The Effect of Fixed-Dose Combination of Insulin Degludec and Liraglutide on Serum Lipoprotein Metabolism in Patients with Type 2 Diabetes Mellitus

Diabetes ◽

10.2337/db20-135-or ◽

2020 ◽

Vol 69 (Supplement 1) ◽

pp. 135-OR

Author(s):

ELENI PAPPA ◽

CHRISTINA KOSTARA ◽

CONSTANTINOS TELLIS ◽

ALEXANDROS D. TSELEPIS ◽

ELENI BAIRAKTARI ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Lipoprotein Metabolism ◽

Serum Lipoprotein ◽

Insulin Degludec ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Dose Combination

Download Full-text

Phase 3 randomized, controlled clinical trial of bictegravir coformulated with FTC/TAF in a fixed-dose combination (B/F/TAF) vs dolutegravir (DTG) + F/TAF in treatment-naïve HIV-1 positive adults: week 48 results

10.26226/morressier.5aeaf2d35800a00019097f85 ◽

2018 ◽

Author(s):

Christian Wisskirchen ◽

Hans-Jürgen Stellbrink

Keyword(s):

Clinical Trial ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Controlled Clinical Trial ◽

Randomized Controlled Clinical Trial ◽

Phase 3 ◽

Randomized Controlled ◽

Treatment Naïve ◽

Dose Combination ◽

Hiv 1

Download Full-text

A Two-Arm Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Chinese Participants With HER2-Positive Early Breast Cancer

Case Medical Research ◽

10.31525/ct1-nct04024462 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Early Breast Cancer ◽

Subcutaneous Administration ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Efficacy And Safety ◽

Her2 Positive ◽

Dose Combination

Download Full-text

Switching to a Fixed Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in HIV-1 Infected Marginalized Populations Who Are Virologically Suppressed

Case Medical Research ◽

10.31525/ct1-nct04132674 ◽

2019 ◽

Author(s):

Keyword(s):

Fixed Dose Combination ◽

Fixed Dose ◽

Marginalized Populations ◽

Dose Combination ◽

Tenofovir Alafenamide ◽

Hiv 1

Download Full-text

A Study of Macitentan and Tadalafil as a Fixed Dose Combination and the Free Combination in Healthy Adult Participants

Case Medical Research ◽

10.31525/ct1-nct04235270 ◽

2020 ◽

Author(s):

Keyword(s):

Healthy Adult ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Adult Participants ◽

Dose Combination

Download Full-text

Faculty Opinions recommendation of Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.3447957.3171054 ◽

2010 ◽

Author(s):

Takahiko Nakagawa

Keyword(s):

High Risk ◽

Randomised Controlled Trial ◽

Cardiovascular Events ◽

Controlled Trial ◽

Secondary Analysis ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Combination Therapies ◽

Dose Combination ◽

Randomised Controlled

Download Full-text